Oxford BioMedica (GB:OXB) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oxford Biomedica has announced its total voting rights, with its issued share capital comprising 105,938,933 ordinary shares, reflecting its strategic position as a leader in cell and gene therapy. The company, renowned for its innovation in viral vector manufacturing, collaborates with top pharmaceutical firms globally. As a FTSE4Good constituent, OXB continues to drive advancements in the biotech sector from its multiple facilities across the UK, France, and the US.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
